Results of treatment of imminent premature labour with the preparation Salbupart-POLFA
- PMID: 2634219
Item in Clipboard
Results of treatment of imminent premature labour with the preparation Salbupart-POLFA
Mater Med Pol.
1989 Jan-Mar.
Abstract
The preparation Salbupart POLFA was used in 40 pregnant women in the treatment of imminent premature labour. The tocolytic effect of the drug was confirmed, especially in pregnancy over 32 weeks. The observed side effects, mainly in the cardiovascular system, did not require drug withdrawal, but tended towards the necessity of using symptom-alleviating drugs such as Isoptin.
Similar articles
-
Assessment of the direct tocolytic action of salbupart and fenoterol in the treatment of imminent premature labour.Mater Med Pol. 1988 Jul-Sep;20(3):194-6. Mater Med Pol. 1988. PMID: 3244294 No abstract available.
-
[Treatment of threatened preterm labor with partusisten and salbupart].Vestn Akad Med Nauk SSSR. 1990;(5):26-9. Vestn Akad Med Nauk SSSR. 1990. PMID: 2152446 Russian.
-
Serum PGF2 alpha concentration during tocolysis effected with Salbupart "Polfa" in imminent premature labour.Mater Med Pol. 1988 Oct-Dec;20(4):281-3. Mater Med Pol. 1988. PMID: 3249549 No abstract available.
-
[Drug treatment of threatened premature labor].Rev Fr Gynecol Obstet. 1995 May-Jun;90(5-6):297-301. Rev Fr Gynecol Obstet. 1995. PMID: 7569592 Review. French.
-
Magnesium sulfate: the first-line tocolytic.Obstet Gynecol Clin North Am. 2005 Sep;32(3):485-500. doi: 10.1016/j.ogc.2005.03.002. Obstet Gynecol Clin North Am. 2005. PMID: 16125045 Review.
MeSH terms
Substances
LinkOut - more resources
Medical